Read or download the full Economic Impact Assessment report Read more

Plurify

Cell and Gene

Plurify develop innovative solutions for efficiently differentiating PSCs to highly pure populations of transplantable cells. This approach will generate numerous therapeutics at scale and revolutionise cell therapies for many diseases with high unmet need.

See other Cell and Gene organisations

Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting clonal neoantigens: protein markers unique to the individual ...
Aglaris Ltd produce equipment to ensure cell and tissue culture is an easy, problem-free task.
Autolus is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London ...
The Cell and Gene Therapy Catapult was established in 2012 as an independent centre of excellence to advance…

Be part of SBC Catalyser Programme!

Spaces are limited to 10 companies per cohort. Contact Marco to get more information on our next programme in spring 2024.

Contact Marco

Designed and built by Onespacemedia

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.